Andrew Zolopa
Overview
Explore the profile of Andrew Zolopa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berko J, Mazonson P, Short D, Karris M, Ehui L, Gutner C, et al.
Antivir Ther
. 2023 Nov;
28(6):13596535231216311.
PMID: 38031911
Older people living with HIV (PLWH) often experience elevated levels of depression, anxiety, and loneliness. This waitlist-controlled trial examined the effectiveness of online audio mindfulness lessons in impacting these feelings...
2.
Fernvik E, Sierra Madero J, Espinosa N, Gulminetti R, Hagins D, Tsai H, et al.
J Acquir Immune Defic Syndr
. 2023 Oct;
94(3):e9-e12.
PMID: 37850985
No abstract available.
3.
Mazonson P, Berko J, Lowman E, Gilliam B, Nwafor T, Clark A, et al.
AIDS Res Hum Retroviruses
. 2023 Jun;
39(10):541-546.
PMID: 37379478
Many men age 50+ with HIV (MWH age 50+) are sexually active. However, little is known about the relationship between the number of sexual partners and patient-reported outcomes in this...
4.
Orkin C, Schapiro J, Perno C, Kuritzkes D, Patel P, DeMoor R, et al.
Clin Infect Dis
. 2023 Jun;
77(10):1423-1431.
PMID: 37340869
Background: Previously reported post hoc multivariable analyses exploring predictors of confirmed virologic failure (CVF) with cabotegravir + rilpivirine long-acting (CAB + RPV LA) were expanded to include data beyond week...
5.
Rawlings M, Letang E, Quercia R, Grove R, DeMasi R, Min S, et al.
Open Forum Infect Dis
. 2022 Sep;
9(8):ofac304.
PMID: 36046700
Background: In HIV clinical trials, proportions of Black and female participants achieving virologic suppression (VS) are often lower compared with White and male participants. As the antiretroviral therapy (ART) landscape...
6.
Ait-Khaled M, Sierra Madero J, Estrada V, Gulminetti R, Hagins D, Tsai H, et al.
HIV Res Clin Pract
. 2021 Dec;
23(1):9-14.
PMID: 34913844
GEMINI-1 and GEMINI-2 (ClinicalTrials.gov, NCT02831673 and NCT02831764, respectively) are double-blind, multicenter, phase III studies that demonstrated the non-inferiority of once-daily dolutegravir + lamivudine to dolutegravir + tenofovir disoproxil fumarate/emtricitabine in...
7.
Berko J, Mazonson P, Loo T, Grant P, Zolopa A, Spinelli F, et al.
AIDS Behav
. 2021 Oct;
26(5):1448-1455.
PMID: 34698952
Resilience, a measure of stress coping ability, may be important in helping older people (age 50+) living with HIV (PLWH) age successfully, but limited data exist regarding factors that contribute...
8.
Karris M, Berko J, Mazonson P, Loo T, Spinelli F, Zolopa A
AIDS Res Hum Retroviruses
. 2020 Jun;
36(8):663-669.
PMID: 32515203
People living with HIV (PLWH) experience chronic pain that may impact function. Gaps in knowledge exist for factors that impact pain and pain medication use in older (age 50+) PLWH....
9.
Mazonson P, Berko J, Loo T, Kane M, Zolopa A, Spinelli F, et al.
AIDS Care
. 2020 Feb;
33(3):375-382.
PMID: 32048520
Loneliness is common among older (age 50+) people living with HIV (PLWH). However, little is known about the prevalence of loneliness across subgroups of older PLWH, and the factors that...
10.
Demarest J, Underwood M, St Clair M, Dorey D, Brown D, Zolopa A
AIDS Res Hum Retroviruses
. 2018 Feb;
34(4):343-346.
PMID: 29444582
In the SAILING study, dolutegravir demonstrated superior virologic efficacy compared with raltegravir in treatment-experienced, integrase strand transfer inhibitor (INSTI)-naive patients with HIV-1 who harbored resistance to ≥2 antiretroviral drug classes....